v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 6 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:        
Net income (loss) $ 2,185,047 $ (12,446,470) $ (8,076,982) $ (6,979,488)
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Depreciation and amortization 25,439 21,322 48,572 22,908
Accretion of discount on convertible debt 625,000 1,093,650 1,993,650   
Amortization of deferred financing costs 152,000 1,261,121 2,149,491   
Warrants issued for services (1,331) 95,292 132,707   
Share based compensation 135,108 123,426 356,702 560,880
Interest accretion in related party note payable    15,781 15,781 91,219
Shares issued for consulting services 229,997 184,000 184,000 365,500
Change in fair value of warrants (5,429,786) 5,565,771 (5,452,436) 1,935,256
Accrued interest income - related party        (10,440)
Accrued registration penalty        156,000
Change in derivative liability    (209,351) (209,351)   
Loss on extinguishment of debt    2,950,513 2,950,513   
Accrued interest-related party     (2,354) 33
Impairment of investments     150,000 522,100
Inventory write-down     347,720   
Changes in opertating assets and liabilities:        
Accounts receivable 1,318,387 (51,959) (1,972,924) 72,003
Advances on inventory purchases (362,388) (766,182) (304,702)   
Inventories (1,519,638) (269,967) (1,907,927) 45,081
Prepaid expenses and other current assets (341,277) (87,424) (115,693) 18,800
Other non-current assets (2,185)       
Accounts payable 425,509 (153,508) 100,754 266,392
Deferred revenue (30,000) (46,152) (54,902) (2,202)
Accrued expenses and other current liabilities (191,160) 69,658 493,369 47,276
Net cash used in operating activities (2,781,278) (2,650,479) (9,174,012) (3,032,698)
Cash flows from investing activities:        
Investments        (582,100)
Deposit on asset acquisition    (40,000) (67,254)   
Increase in note receivable (500,000)       
Certificate of deposit - non current (298)    (50,000)   
Reverse recapitalization transaction        (320,000)
Purchase of intangible assets (1,565,525)       
Additions to property, plant and equipment (3,627) (49,150) (95,840) (85,955)
Net cash used in investing activities (2,069,450) (89,150) (213,094) (988,055)
Cash flows from financing activities:        
Proceeds from issuance of convertible debt 1,275,000 2,550,000 2,550,000   
Costs associated with convertible debt (157,175) (342,586) (342,586)   
Proceeds of notes payable 109,699 29,180 89,514 27,293
Repayment of notes payable (68,337) (9,714) (70,491) (67,579)
Repayment of loans from related parties        (513)
Deferred offering costs    (7,500)    (63,500)
Proceeds from private placements of common stock    1,170,000 13,670,000 4,475,000
Costs associated with private placement of common stock    (192,400) (1,861,647) (389,437)
Net cash provided by financing activities 1,159,187 3,196,980 14,034,790 3,981,264
Net increase (decrease) in cash and cash equivalents (3,691,541) 457,351 4,647,684 (39,489)
Cash and cash equivalents - beginning of period 4,683,186 35,502 35,502 74,991
Cash and cash equivalents - end of period 991,645 492,853 4,683,186 35,502
Supplemental disclosures of cash flow information        
Interest paid in cash 1,219 3,314 9,361 96,841
Taxes paid in cash            
Non Cash Investing and Financing Activities        
Common shares issued on conversion of related party note payable     107,000 687,500
Common shares issued in payment of related party receivables 229,997      151,400
Common shares issued towards asset acquisition 860,112 500,000 500,000   
Warrants issued with debt 275,936 3,606,399 811,447  
Cashless exercise of placement agent warrants    3,594,435 3,954,435   
Deferred offering costs    63,500 63,500   
Beneficial conversion feature on related party loan 533,032 243,711 243,711   
Settlement of derivative liabilities   13,323 13,323   
Warrant issued for asset acquisition 241,880       
Liability recorded for asset acquisition 50,000       
Insurance premiums financed through notes payable 99,699 38,875    
Warrant liabilities     29,067,319 2,182,732
Common Shares issued in conversion of notes payable     $ 4,980,763